Skip to main content
Supplement ScienceSupplementScience

Benefits of Vitamin B1 (Thiamine)

Evidence:Strong
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Energy metabolism — thiamine pyrophosphate is a required cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase, linking glycolysis to the citric acid cycle; without B1, cells cannot efficiently produce ATP from glucose
  • Nervous system support — thiamine is essential for myelin sheath maintenance and acetylcholine synthesis; deficiency causes peripheral neuropathy, cognitive impairment, and in severe cases Wernicke encephalopathy
  • Diabetic neuropathy — a 2008 RCT found benfotiamine at 300 mg/day significantly improved neuropathy symptom scores in diabetic patients over 6 weeks compared to placebo
  • Cardiovascular health — thiamine is critical for cardiac muscle energy production; deficiency causes wet beriberi with heart failure, and supplementation improves cardiac function in heart failure patients with low thiamine status

What the Research Says

Vitamin B1 (Thiamine) is essential for energy metabolism and neurological function. Stracke et al. (2008) demonstrated that benfotiamine, a thiamine analog, at 300 mg/day significantly improved neuropathy symptoms in patients with type 1 and type 2 diabetes, highlighting its potential in managing diabetic complications. Whitfield et al. (2018) underscored the underdiagnosis of thiamine deficiency globally, particularly among high-risk populations such as alcoholics, elderly individuals, and heart failure patients, emphasizing the need for better diagnostic strategies and public health interventions.

Schoenenberger et al. (2012) conducted a randomized, double-blind, placebo-controlled pilot study showing that thiamine supplementation improved left ventricular ejection fraction in heart failure patients with thiamine deficiency, suggesting its role in cardiovascular management. Additionally, Manzardo et al. (2015) found that benfotiamine treatment reduced psychiatric symptoms in males with high lifetime alcoholism severity, while Manzardo et al. (2013) demonstrated that benfotiamine supplementation significantly reduced alcohol consumption in women with severe alcohol dependence compared to placebo. These studies highlight the potential of thiamine analogs in addressing both neurological and behavioral aspects of chronic alcohol use.

Overall, these findings emphasize the importance of thiamine in maintaining neurological health and its therapeutic potential across various clinical conditions.

Related Conditions

EnergyBrain Fog
Full Vitamin B1 (Thiamine) Guide

References

  1. RCTStracke H, Gaus W, Achenbach U, Federlin K, Bretzel RG (2008). Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Experimental and Clinical Endocrinology & Diabetes. DOI PubMed
  2. ReviewWhitfield KC, Bourassa MW, Adamolekun B, et al. (2018). Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Annals of the New York Academy of Sciences. DOI PubMed
  3. RCTSchoenenberger AW, Schoenenberger-Berzins R, der Maur CA, et al. (2012). Thiamine supplementation in symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled, cross-over pilot study. Clinical Research in Cardiology. DOI PubMed
  4. Turkia M (2020). The History of Methylprednisolone, Ascorbic Acid, Thiamine, and Heparin Protocol and I-MASK+ Ivermectin Protocol for COVID-19.. Cureus. DOI PubMed
  5. RCTManzardo AM, Pendleton T, Poje A, Penick EC, et al. (2015). Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity.. Drug and alcohol dependence. DOI PubMed
  6. Himmerich H, Erbguth F (2014). [Nutrition and dietary supplements in psychiatric diseases].. Der Nervenarzt. DOI PubMed
  7. RCTManzardo AM, He J, Poje A, Penick EC, et al. (2013). Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.. Drug and alcohol dependence. DOI PubMed